AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook or LinkedIn.
Founded in 2014, Aledade offers a new model of primary care that keeps physicians right where they want to be: building strong, impactful relationships with their patients. Aledade has grown rapidly and currently partners with hundreds of practices responsible for nearly 1.2 million patients across 32 states to support the delivery of seamless, affordable, high-quality care. Learn more about value based care and the Aledade difference at www.Aledade.com.
As part of our commitment to be “With Primary Care, For Primary Care,” Aledade is pleased to be a CAFP Partner in Health and share how value-based care, led by primary care physicians and community health centers, is bringing sustainable revenue and better quality outcomes to patients in California and all across the country.
Please enjoy our “Comprehensive Guide to Value-Based Care for Primary Care Physicians”, a free resource with more information on the fundamental building blocks of value-based care.
AstraZeneca is excited to be a Partner in Health with the California Academy of Family Physicians. This partnership allows us to pursue our values: to follow the science and put patients first. Through the AIRS, or AstraZeneca Innovating Respiratory Science, Education Network, we look forward to providing you with educational content that highlights emerging science in respiratory diseases. In the spirit of true partnership, to enhance our support in delivering relevant education, please send any suggestions and feedback to Jerri Davis.
In this brief video, a primary care physician examines the burden of COPD in the United States, discusses the impact acute COPD exacerbations can have on patients, and highlights the importance of exacerbation prevention.
Boehringer Ingelheim presents education on Pulmonary Fibrosis. Pulmonary fibrosis is a common threat across interstitial lung diseases (ILDs), a group of serious lung diseases—some with a fatal prognosis. It is critical to recognize and refer patients with suspected ILD to a lung specialist to help them access the treatment they need.